Manage Your Communication Preferences

Manage Your Communication Preferences

If you no longer wish to receive communications from Takeda, enter your email address and check the box(es) below to indicate which communications you no longer wish to receive. You may choose to either unsubscribe from all communications or only certain types of communications. Click Submit when finished.

*Email

I no longer wish to receive information regarding:

HAE events
Invitations to attend upcoming events in your area and other related communications.

Cinryze treatment information
Resources and updates about specific treatment options.

HAE education
Notifications about disease education resources available for HAE patients and caregivers.

Takeda Patient Support marketing content
Resources and information related to Takeda Patient Support tools and programs.
Only applicable for those enrolled in Takeda Patient Support. Please note that if you are currently enrolled in Takeda Patient Support, you will continue to receive product support communications from your Patient Support Manager but will not receive marketing communications about Takeda Patient Support resources.

Unsubscribe from all Takeda marketing communications

By clicking the box below, you are opting out of all marketing messages from Takeda. Please note that if you are currently enrolled in Takeda Patient Support, you will continue to receive product support communications from your Patient Support Manager but will not receive marketing communications about Takeda Patient Support resources.

Unsubscribe from all

ExpandClose Important Safety Information

You should not use CINRYZE if you have had life-threatening immediate hypersensitivity reactions, including anaphylaxis, to the product.

Tell your healthcare provider about all of your medical conditions, including if you have an indwelling catheter/access device in one of your veins; have a history of blood clots, heart disease, or stroke; or are taking birth control pills or androgens. Also tell your healthcare provider if you are pregnant or planning to become pregnant, or are breastfeeding or planning to breastfeed. It is not known if CINRYZE can harm your unborn baby, or if CINRYZE passes into your milk and if it can harm your baby.

Allergic reactions may occur with CINRYZE. Call your healthcare provider or get emergency support services right away if you have any of the following symptoms: wheezing, difficulty breathing, chest tightness, turning blue (look at lips and gums), fast heartbeat, swelling of the face, faintness, rash, hives.

Serious blood clots may occur with CINRYZE. Call your healthcare provider or get emergency support services right away if you have any of the following symptoms: pain and/or swelling of an arm or leg with warmth over the affected area, discoloration of an arm or leg, unexplained shortness of breath, chest pain or discomfort that worsens on deep breathing, unexplained rapid heart rate, numbness or weakness on one side of the body.

Because CINRYZE is made from human blood, it may carry a risk of transmitting infectious agents, e.g., viruses and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent.

The most common side effects seen with CINRYZE were headache, nausea, rash, and vomiting. These are not all the possible side effects of CINRYZE. Tell your healthcare provider about any side effect that bothers you or that does not go away. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

For additional safety information, please click here for Full Prescribing Information and discuss with your doctor.

You are encouraged to report negative side effects of prescription drugs to the FDA.

Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

©2024 Takeda Pharmaceuticals U.S.A., Inc., 500 Kendall Street, Cambridge, MA 02142. 1-877-TAKEDA-7 (1-877-825-3327). All rights reserved. TAKEDA^®, the TAKEDA Logo^® and the TAKEDA Patient Support Logo™ are registered trademarks of Takeda Pharmaceutical Company Limited. CINRYZE^® and the CINRYZE Logo^® are registered trademarks of Viropharma Biologics LLC.

US-CIN-0180v1.0 10/24

Definition: